Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Director departure
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
OSI PHARMACEUTICALS INC (OSIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/06/2010 |
8-K
| Amended existing or entered into new employment agreement with an officer|
Docs:
|
"OSI Change in Control Severance Plan, adopted by the OSI Board upon recommendation of the Compensation Committee of OSI Board on April 2, 2010",
"Prosidion Limited and OSI Pharmaceuticals (UK) Limited Change in Control Severance Plan, adopted by the OSI Board upon recommendation of the Compensation Committee of OSI Board on April 2, 2010",
"Amendment to Employment Agreement, by and between OSI Pharmaceuticals, Inc. and Dr. Jonathan Rachman",
"Employment Letter Agreement, by and between OSI Pharmaceuticals, Inc. and Dr. David Epstein",
"Amendment to Employment Letter Agreement, by and between OSI Pharmaceuticals, Inc. and Dr. David Epstein",
"Employment Letter Agreement, by and between OSI Pharmaceuticals, Inc. and Dr. Angela Davies",
"Amendment to Employment Letter Agreement, by and between OSI Pharmaceuticals, Inc. and Dr. Angela Davies",
"OSI Pharmaceuticals Announces Conversion Period for Convertible Notes",
"Conversion Notice for 2.0% Convertible Senior Subordinated Notes due 2025 of OSI Pharmaceutials, Inc." |
|
|
|